Indalo Therapeutics

PharmaceuticalsSeries ASt. Louis, USindalotherapeutics.com

Latest round

Series A

Last raised

Jan 2019

Total raised

$26M

Investors

6

About Indalo Therapeutics

Based in Missouri, US, and founded in 2016, Indalo Therapeutics, Inc operates as a biopharmaceutical company that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF)., and Antegrin Therapeutics LLC. In January 2019, Indalo Therapeutics, Inc. The company's IDL-2965 is an oral, selective antagonist of RGD-binding integrins avb1, avb3, and avb6 that inhibits numerous stages of pathologic fibrosis, including the local stimulation of TGF-b by both epithelial cells and fibroblasts.

Who invested in Indalo Therapeutics

6 investors across 2 rounds

See all investors in Indalo Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jan 28, 2019

    Amount

    $17M

    Investors

    Locked

  2. Series A

    Jun 30, 2017

    Amount

    $9M

    Investors

    Locked

Questions about Indalo Therapeutics

Who invested in Indalo Therapeutics?

Indalo Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Indalo Therapeutics raised?

Indalo Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Indalo Therapeutics last raise money?

Indalo Therapeutics's most recent round on record is a Series A, in Jan 2019.

What does Indalo Therapeutics do?

Based in Missouri, US, and founded in 2016, Indalo Therapeutics, Inc operates as a biopharmaceutical company that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF).

Where is Indalo Therapeutics headquartered?

Indalo Therapeutics is headquartered in St. Louis, US.

Which VCs invest in companies like Indalo Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Indalo Therapeutics's stage. Their profiles are linked below.

Raising like Indalo Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.